Quentin VICARD

Quentin VICARD has a diverse work experience spanning various roles and responsibilities. Quentin started their career in 2012 as a Worker at EIFFAGE. In 2013, they participated in the iGEM competition at IGEM Insa Toulouse. Quentin then worked as a Junior consultant in Marketing & Strategy for Pharmaceutical industries and Biotechs at Novoptim from February 2014 to July 2014.

From 2015 to 2020, they joined Sartorius Stedim Biotech, where they held multiple positions, including Field Marketing Manager - Single Use Bag Integrity testing - EU & Asia, Application Specialist - Fluid Management Technologies - North Europe & Nemea, Technical Expert - Regenerative Medicine - EU, and Technical consultant - Cell and Gene therapy - EU. In these roles, Quentin was involved in implementing Single Use Technologies, project management, operator training, complaint analysis, and cross-selling initiatives.

In 2020, Quentin established their own consultancy firm, CellaVic CGT Consulting, where they served as the Owner and Consultant. There, they provided strategic advice and guidance to clients in the biotechnology and cell therapy industries.

Later, they transitioned to Ori Biotech in 2022, assuming the position of Director of Product Management until January 2023.

Currently, Quentin VICARD holds the role of Director of Strategy and Alliance Management at Core Biogenesis, a position they started in February 2023.

Quentin Vicard completed their Master's degree in Biochemistry Engineering from the Institut national des Sciences appliquées de Toulouse from 2011 to 2013. In 2012, they also participated in the Erasmus program at the Norwegian University of Science and Technology (NTNU), where they focused on Biotechnology-Biochemistry. Following that, from 2013 to 2015, Quentin pursued another Master's degree in Management and Business of High Tech Innovation at TBS Education.